Incidence and sites of distant metastases from head and neck cancer

A Ferlito, AR Shaha, CE Silver, A Rinaldo, V Mondin - ORL, 2001 - karger.com
The incidence of distant metastases in head and neck squamous cell carcinoma (SCC) is
relatively small in comparison to other malignancies. Distant metastases adversely impact …

[HTML][HTML] Peripheral lymphadenopathy: approach and diagnostic tools

S Mohseni, A Shojaiefard, Z Khorgami… - Iranian journal of …, 2014 - ncbi.nlm.nih.gov
Peripheral lymph nodes, located deep in the subcutaneous tissue, clean antigens from the
extracellular fluid. Generally, a normal sized lymph node is less than one cm in diameter …

Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes

I Ganly, V Makarov, S Deraje, YY Dong, E Reznik… - Cancer cell, 2018 - cell.com
The molecular foundations of Hürthle cell carcinoma (HCC) are poorly understood. Here we
describe a comprehensive genomic characterization of 56 primary HCC tumors that span …

Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in Hürthle cell carcinoma

RK Gopal, K Kübler, SE Calvo, P Polak, D Livitz… - Cancer Cell, 2018 - cell.com
Hürthle cell carcinoma of the thyroid (HCC) is a form of thyroid cancer recalcitrant to
radioiodine therapy that exhibits an accumulation of mitochondria. We performed whole …

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to …

RM Tuttle, H Tala, J Shah, R Leboeuf, R Ghossein… - Thyroid, 2010 - liebertpub.com
Background: A risk-adapted approach to management of thyroid cancer requires risk
estimates that change over time based on response to therapy and the course of the …

The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland

IJ Nixon, MM Whitcher, FL Palmer, RM Tuttle… - Thyroid, 2012 - liebertpub.com
Background: Distant metastases at presentation are rare in well-differentiated thyroid cancer
(WDTC). The objective of this study was to report outcomes for patients presenting with …

Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring BRAFV600E Mutation

KB Kim, ME Cabanillas, AJ Lazar, MD Williams… - Thyroid, 2013 - liebertpub.com
Background: Clinical benefit from cytotoxic chemotherapy for metastatic papillary thyroid
carcinoma (PTC) is disappointing, and effective therapeutic approaches for these patients …

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy

I Ganly, J Ricarte Filho, S Eng… - The Journal of …, 2013 - academic.oup.com
Context: Hurthle cell cancer (HCC) is an understudied cancer with poor prognosis.
Objective: Our objective was to elucidate the genomic foundations of HCC. Design and …

Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence

JL Roh, JM Kim, CI Park - Annals of surgical oncology, 2011 - Springer
Background Although subclinical cervical lymph node (LN) metastases in papillary thyroid
carcinoma (PTC) are common, the efficacy of prophylactic central LN dissection (CLND) is …

Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer

AR Shaha - The Laryngoscope, 2004 - Wiley Online Library
Abstract Objectives/Hypothesis The outcome in differentiated thyroid cancer generally
depends on the stage of the disease at the time of presentation; prognostic factors such as …